Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the study details, eligibility criteria, and locations remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:39.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The Locations section now lists 11 sites, adding L'Hospitalet de Llobregat, Barcelona, Spain, and removing Lyon, France. The total number of locations changed from 12 to 11, and the L'Hospitalet de Llobregat entry was reformatted from Catalonia to Barcelona.
    Difference
    0.5%
    Check dated 2025-10-27T09:23:52.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:42:19.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T11:14:15.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.0.2 is now shown, replacing v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:38:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:31:12.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.